Login to Your Account

BioNet Holding Banks on Scil Proteins with $33M Financing

By Marie Powers

Thursday, February 3, 2011
Privately held Scil Proteins GmbH, of Halle, Germany, has concluded a financing round with BioNet Holding GmbH, worth €24 million ($33.1 million). The funds will be used to move two preclinical products derived from Scil Proteins' Affilin scaffold technology platform into Phase I studies over the next three years.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription